Trials / Conditions / Waldenstrom Macroglobulinemia (WM)
Waldenstrom Macroglobulinemia (WM)
3 registered clinical trials studyying Waldenstrom Macroglobulinemia (WM) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies NCT05131022 | Nurix Therapeutics, Inc. | Phase 1 |
| Recruiting | A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies NCT04830137 | Nurix Therapeutics, Inc. | Phase 1 |
| Completed | Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors NCT03771157 | University of Rochester | EARLY_Phase 1 |